Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SP-002 |
Trade Name | |
Synonyms | SP002|SP 002 |
Drug Descriptions |
SP-002 inhibits USP1, which potentially decreases growth of tumors with homologous repair deficiency (Cancer Res (2023) 83 (7_Supplement): 6201). |
DrugClasses | USP1 inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Olaparib + SP-002 | Olaparib SP-002 | 0 | 0 |
SP-002 | SP-002 | 0 | 0 |
SP-002 + Vismodegib | SP-002 Vismodegib | 0 | 1 |